日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SOX5 inhibition overcomes PARP inhibitor resistance in BRCA-mutated breast and ovarian cancer

SOX5抑制剂可克服BRCA突变型乳腺癌和卵巢癌中的PARP抑制剂耐药性

Mithun Ghosh ,Min Sil Kang ,Nar Bahadur Katuwal ,Sa Deok Hong ,Seong Min Park ,Seul-Gi Kim ,Seung Ryeol Lee ,Yong Wha Moon

Differentially Charged Liposomes Stimulate Dendritic Cells with Varying Effects on Uptake and Processing When Used Alone or in Combination with an Adjuvant

不同电荷的脂质体单独使用或与佐剂联合使用时,对树突状细胞的摄取和处理产生不同的影响。

Maji, Mithun; Ghosh, Sneha; Didwania, Nicky; Ali, Nahid

Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer

曲妥珠单抗介导的抗体依赖性细胞介导的细胞毒性 (ADCC) 增强了 HER2 过表达卵巢癌中的自然杀伤细胞的细胞毒性

Sa Deok Hong, Nar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, Seong Min Park, Tae Hoen Kim, Young Seok Baek, Seung Ryeol Lee, Yong Wha Moon

Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer

以PEG10为靶点,探索克服乳腺癌CDK4/6抑制剂耐药性的新型治疗方法

Nar Bahadur Katuwal,Min Sil Kang,Mithun Ghosh,Sa Deok Hong,Yeong Gyu Jeong,Seong Min Park,Seul-Gi Kim,Joohyuk Sohn,Tae Hoen Kim,Yong Wha Moon

Pseudomonas Aeruginosa Theft Biofilm Require Host Lipids of Cutaneous Wound

铜绿假单胞菌生物膜的形成需要皮肤伤口的宿主脂质

Sinha, Mithun; Ghosh, Nandini; Wijesinghe, Dayanjan S; Mathew-Steiner, Shomita S; Das, Amitava; Singh, Kanhaiya; El Masry, Mohamed; Khanna, Savita; Inoue, Hiroyuki; Yamazaki, Katsuhisa; Kawada, Manabu; Gordillo, Gayle M; Roy, Sashwati; Sen, Chandan K

PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer

PSPC1 抑制剂与聚(ADP-核糖)聚合酶抑制剂在 BRCA 突变乳腺癌/卵巢癌临床前模型中发挥协同作用

Mithun Ghosh, Min Sil Kang, Nar Bahadur Katuwal, Sa Deok Hong, Yeong Gyu Jeong, Seong Min Park, Seul-Gi Kim, Yong Wha Moon

Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer

PI3K 抑制剂与 Eribulin 联合使用可增强紫杉醇耐药、PIK3CA 突变子宫内膜癌临床前模型中的抗肿瘤活性

Yeong Gyu Jeong, Nar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, Sa Deok Hong, Seong Min Park, Seul-Gi Kim, Tae Hoen Kim, Yong Wha Moon

Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer

ATR 抑制剂 AZD6738 与喜树碱类似物贝洛替康联合治疗化疗耐药性卵巢癌的协同作用

Jin Hur, Mithun Ghosh, Tae Heon Kim, Nahee Park, Kamal Pandey, Young Bin Cho, Sa Deok Hong, Nar Bahadur Katuwal, Minsil Kang, Hee Jung An, Yong Wha Moon